OPRC_Banner_Logo

Dates


Presentations


Presentations

  • Obstetric Fetal Pharmacology Research Centers and Preeclampsia.

    Wisner K.L., Stika C.S. (2016 Jun). Obstetric Fetal Pharmacology Research Centers and Preeclampsia. Women’s Health Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Mood symptoms in medicated vs. unmedicated women with bipolar disorder during pregnancy.

    Wisner K.L. (2016 May). Mood symptoms in medicated vs. unmedicated women with bipolar disorder during pregnancy. The 18th Conference of the International Society of Psychosomatic Obstetrics and Gynaecology, Malaga, Spain.
  • Antidepressants and Anxiolytics.

    Wisner K.L. (2016 Apr). Antidepressants and Anxiolytics. North American Society for Psychosocial Obstetrics and Gynecology Biennial Meeting, New York, NY.
  • Comprehensive Evaluation of the Safety and Utility of Pravastatin in Prevention of Preeclampsia in High-Risk Pregnant Women.

    Stika C.S. (2016 Apr). Comprehensive Evaluation of the Safety and Utility of Pravastatin in Prevention of Preeclampsia in High-Risk Pregnant Women. Department of Obstetrics and Gynecology Grand Rounds, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Use of Medications During Pregnancy and Breastfeeding: Maternal, Fetal, and Neonatal impact.

    Costantine M. M. (2016 Mar). Use of Medications During Pregnancy and Breastfeeding: Maternal, Fetal, and Neonatal impact. American Society of Clinical Pharmacology and Therapeutics Annual Meeting, Science at Sunrise Session. San Diego, CA.
  • Use of Pravastatin for Recurrent Preeclampsia

    Costantine M. (2014 Oct). Use of Pravastatin for Recurrent Preeclampsia. Presentation at the ISSHP XIX World Congress Meeting, New Orleans, LA.
  • Hydralazine Pharmacokinetics in Pregnancy

    Cusumano M, Ryu R, Easterling TR, Shen D, Thummel K, Hebert MF (2014 Oct). Hydralazine Pharmacokinetics in Pregnancy. American College of Clinical Pharmacy Annual Meeting, Austin, TX.
  • What’s New in Drug Therapy for Pregnancy? A Clinical Pharmacology Update

    Hebert, MF (2014 Oct). What’s New in Drug Therapy for Pregnancy? A Clinical Pharmacology Update. Advanced Practice in Primary and Acute Care Conference. Seattle, WA.
  • Of pregnant women and mice: maternal-fetal disposition of glyburide during pregnancy and implications for the treatment of gestational diabetes mellitus

    Mao, Q (2014 May). Of pregnant women and mice: maternal-fetal disposition of glyburide during pregnancy and implications for the treatment of gestational diabetes mellitus. Invited Seminar for Anatomy and Pharmacology Joint Program Seminar, School of Medicine, Queen’s University, Kingston, Ontario, Canada.
  • Expression and its Effect on Metformin Disposition in Pregnancy

    Wang J. (2014 May). Expression and its Effect on Metformin Disposition in Pregnancy. Obstetric-Fetal Pharmacology Research Units Network, NIH-NICHD, Rockville, MD.
  • Drugs in Pregnancy: Treating the Mother, Protecting the Unborn

    Hebert, MF (2014 Apr). Drugs in Pregnancy: Treating the Mother, Protecting the Unborn. 2013-14 NICHD’s Principles of Pediatric Clinical Pharmacology (Webinar).
  • Maternal-Fetal Disposition of Glyburide in Pregnant Mice Is Dependent on Gestational Age

    Shuster DL, Risler LJ, Liang JC, Rice KM, Shen DD, Hebert MF, Thummel KE, Mao Q (2014 Apr). Maternal-Fetal Disposition of Glyburide in Pregnant Mice Is Dependent on Gestational Age. The American Society of Pharmacology and Experimental Therapeutics (ASPET) Annual Meeting at Experimental Biology. San Diego, CA.
  • Drugs in Pregnancy and Lactation

    Hebert, MF (2014 Mar). Drugs in Pregnancy and Lactation. Women’s Health Care Update. Seattle, WA.
  • Relationship between glyburide and insulin concentration in women with gestational diabetes

    Feghali M, Hebert MF, Scifres C, Caritis SN (2014 Feb). Relationship between glyburide and insulin concentration in women with gestational diabetes. SMFM, New Orleans, LA.
  • Omeprazole and esomeprazole pharmacokinetics in pregnancy

    Quinney SK, Glassburn J, Hebert MF, Umans JG, Hankins GV, Caritis SN, Flockhart DA, Haas DM (2014 Feb). Omeprazole and esomeprazole pharmacokinetics in pregnancy. SMFM, New Orleans, LA.
  • Pravastatin for the prevention of preeclampsia in high risk women

    Costantine M. (2014 Jan). Pravastatin for the prevention of preeclampsia in high risk women. Presentation at the Indiana University & Riley Hospital, Combined Pediatrics and Obstetrics Grand Rounds, Indianapolis, IN.
  • Polyspecific Organic Cation Transporters in Drug Disposition: beyond the Kidney and the Liver

    Wang J. (2013 Nov). Polyspecific Organic Cation Transporters in Drug Disposition: beyond the Kidney and the Liver. Department of Pharmaceutical Sciences, School of Pharmacy, University at Buffalo, State University of New York, Buffalo, NY.
  • Gestational age-dependent trends in maternal-fetal glyburide pharmacokinetics in pregnant mice

    Shuster, D., Risler, L., Liang, J., Thummel, K., Hebert, M., Shen, D., & Mao, Q. (2013 May). Gestational age-dependent trends in maternal-fetal glyburide pharmacokinetics in pregnant mice. The American Conference on Pharmacometrics (ACoP), Fort Lauderdale, FL.
  • The Organic Cation Transporter 3 (OCT3) facilitates fetal disposition of metformin during pregnancy

    Lee, N., Hebert, M. F., Easterling, T. R., Liang, J., Rice, K., & Wang, J. (2013 Apr). The Organic Cation Transporter 3 (OCT3) facilitates fetal disposition of metformin during pregnancy. Presentation at The Division for Drug Metabolism of The American Society for Pharmacology and Experimental Therapeutics (ASPET) Annual Meeting.
  • Steroid pathway genes and neonatal respiratory distress after betamethasone use in anticipated preterm birth

    Haas, D. M., Lai, D., Sharma, S., Glassburn, J., Tantisira, K., & Foroud, T. (2013 Mar). Steroid pathway genes and neonatal respiratory distress after betamethasone use in anticipated preterm birth. Poster presentation at Annual Meeting, American Society for Clinical Pharmacology and Therapeutics, Indianapolis, IN.
  • The role of endothelial progenitor cell numbers in infants and children on vascular reactivity

    Ahmed, W., Mund, J., Case, J., & Haneline, L. S. (2012 Oct). The role of endothelial progenitor cell numbers in infants and children on vascular reactivity. Midwest Society for Pediatric Research, Columbus, OH.
  • The impact of glucocorticoid polymorphisms on outcomes indicating neonatal respiratory morbidity severity after betamethasone therapy for preterm labor.

    Haas, D. M. (2012 Oct). The impact of glucocorticoid polymorphisms on outcomes indicating neonatal respiratory morbidity severity after betamethasone therapy for preterm labor. Central Association of Obstetricians and Gynecologists annual meeting, Chicago, IL.
  • Distribution of bupropion and its major metabolites in maternal vein, umbilical cord and placental tissue: A pilot study

    (2012 Sep). Distribution of bupropion and its major metabolites in maternal vein, umbilical cord and placental tissue: A pilot study. ACCP Annual Meeting, San Diego, CA.
  • Gene expression profiling of maternal liver, kidney, and small intestine in pregnant mice during pregnancy

    Shuster, D. L., Bammler, T. K., Beyers, R. P., MacDonald, J., Farin, F., Hebert, M. F., Thummel, K. E., & Mao, Q. (2012 Jul). Gene expression profiling of maternal liver, kidney, and small intestine in pregnant mice during pregnancy. Gordon Research Conference: Drug Metabolism, Holderness, MA.
  • Consequences of gestational diabetes, aging, and postnatal dietary stress on metabolism and hematopoiesis

    Blue, E., Ballman, K., Khan, S., & Haneline, L. S. (2012 May). Consequences of gestational diabetes, aging, and postnatal dietary stress on metabolism and hematopoiesis. Pediatric Academic Society Meeting, Boston, MA.
  • Betamethasone pharmacogenetics: Is individualized antenatal corticosteroid therapy on the horizon?

    Haas, D. M. (2012 May). Betamethasone pharmacogenetics: Is individualized antenatal corticosteroid therapy on the horizon?. 2nd Annual Neonatal Symposium, Indianapolis, IN.
  • Maternal-fetal gestational characteristics and microsomal aromatase activity in human placentas

    Zacharias, N., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2012 Feb). Maternal-fetal gestational characteristics and microsomal aromatase activity in human placentas. Society for Maternal-Fetal Medicine 32nd Annual Meeting, Dallas, TX.
  • Exploring cellular biomarkers in pregnancy and pediatrics

    Haneline, L. S. (2012). Exploring cellular biomarkers in pregnancy and pediatrics. Neonatal-Perinatal Medicine Research Seminar, Children’s Hospital of Philadelphia, Philadelphia, PA.
  • Assessing the quality of the evidence for preterm labor tocolysis trials

    Haas, D. M. (2011, October). Assessing the quality of the evidence for preterm labor tocolysis trials. Cochrane Collaboration, 2011 Combined Cochrane and Campbell Colloquia, Keystone, CO.
  • The pharmacokinetics of metoprolol during pregnancy

    Yep, T., Eyal, S., Easterling, T. R., Shen, D. D., Kelly, E., Hankins, G. D. V., Caritis, S., Risler, L., & Hebert, M. F. (2011 Oct). The pharmacokinetics of metoprolol during pregnancy. American College of Clinical Pharmacy Annual Meeting, Pittsburgh PA.
  • HanelinePregnancy11

    https://www2.aap.org/sections/perinatal/presentations/HanelinePregnancy11.pdf
  • Gestational diabetes induces altered function of neonatal endothelial colony forming cell

    DiGuiseppe, R., Derr-Yellin, E., Acosta, J. C., & Haneline, L. S. (2011, May). Gestational diabetes induces altered function of neonatal endothelial colony forming cell. Pediatric Academic Society Meeting, Denver, CO.
  • A semi-mechanistic pharmacokinetic model of midazolam in pregnancy: Alteration of CYP3A activity

    Quinney, S. K., Hebert, M., & Li, L. (2011, April). A semi-mechanistic pharmacokinetic model of midazolam in pregnancy: Alteration of CYP3A activity. American Conference on Pharmacometrics. San Diego, CA.
  • The impact of genotype on neonatal outcomes from antenatal corticosteroid therapy for preterm labor

    Haas, D. M. (2011, March 18). The impact of genotype on neonatal outcomes from antenatal corticosteroid therapy for preterm labor. Society for Gynecologic Investigation, Miami, FL.
  • Pharmacokinetics of bupropion in pregnant women

    Zhan, Y., Wang, X., Rytting, E., Patrikeeva, S. L., Nanovskaya, T. N., Clark, S., Jackson, A., Venkataramanan, R., Caritis, S., Hebert, M., Easterling, T. R., Hankins, G. D. V., & Ahmed, M. S. (2011, February). Pharmacokinetics of bupropion in pregnant women. Society for Maternal Fetal Medicine 31st Annual Meeting, San Francisco, CA.
  • Role of prostaglandin influx and efflux transporters (PGT and MRP4) in human fetal membranes

    216: Role of prostaglandin influx and efflux transporters (PGT and MRP4) in human fetal membranes Harirah, Hassan et al. American Journal of Obstetrics & Gynecology , Volume 201 , Issue 6 , S92
  • Metabolism of 17a-hydroxyprogesteronecaproate (17-P) by human placental mitochondrial and microsomal enzymes

    Zharikova, O. L., Fokina, V. M., Yan, R., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2010, February). Metabolism of 17a-hydroxyprogesteronecaproate (17-P) by human placental mitochondrial and microsomal enzymes. Society for Maternal Fetal Medicine 30th Annual Meeting, Chicago, IL.
  • Consequences of gestational diabetes and adult dietary stress in the aged rat offspring

    Ballman, K., Khan, S., Kono, T., Evans-Molina, C., & Haneline, L. S. (2010, May). Consequences of gestational diabetes and adult dietary stress in the aged rat offspring. Pediatric Academic Society, Vancouver, British Columbia, Canada.
  • Redox regulation of stem cells

    Haneline, L. S. (2010). Redox regulation of stem cells. Gordon Research Conference, Thiol-based Redox Regulation and Signaling, Lucca, Italy.
  • Diabetes in pregnancy: Fetal effects that predispose to later cardiac disease

    Haneline, L. S. (2010). Diabetes in pregnancy: Fetal effects that predispose to later cardiac disease. American Academy of Pediatrics District VIII Section on Perinatal Pediatrics Meeting, Boise, ID.
  • Differential expression of prostaglandin biosynthetic enzymes in human fetal membrane layers during pregnancy and labor

    Harirah, H. M., Nekhayeva, I. A., & Ahmed, M. S. (2010, February). Differential expression of prostaglandin biosynthetic enzymes in human fetal membrane layers during pregnancy and labor. Society for Maternal-Fetal Medicine 30th Annual Meeting, Chicago, IL.
  • Preterm labor- why we hand you babies too soon and what (if anything) we can do about it

    Haas, D. M. (2010, September 4). Preterm labor- why we hand you babies too soon and what (if anything) we can do about it. Pediatric Academic Society, 34th Midwest Conference on Perinatal Research.
  • The impact of genotype on nifedipine pharmacokinetics when used as a tocolytic

    Haas, D. M. (2010, October 29). The impact of genotype on nifedipine pharmacokinetics when used as a tocolytic. Central Association of Obstetricians and Gynecologists, Annual Meeting Las Vegas, NV.
  • Multiple ABC transporters of human placental brush border membranes contribute to the efflux of glyburide, rosiglitazone, and metformin

    Hemauer, S. J., Patrikeeva, S. L., Nanovskaya, T. N., Hankins, G. D., & Ahmed, M. S. (2010, February). Multiple ABC transporters of human placental brush border membranes contribute to the efflux of glyburide, rosiglitazone, and metformin. Oral presentation, Society for Maternal Fetal Medicine 30th Annual Meeting, Chicago, IL.
  • Role of p-glycoprotein and breast cancer resistance protein in the placental biodisposition of bupropion and its metabolic, OH-bupropion

    Hemauer, S. J., Patrikeeva, S. L., Nanovskaya, T. N., & Ahmed, M. S. (2010, June). Role of p-glycoprotein and breast cancer resistance protein in the placental biodisposition of bupropion and its metabolic, OH-bupropion. College on Problems of Drug Dependence 72nd Annual Scientific Meeting, Scottsdale, AZ.
  • Pharmacokinetics of famotidine during pregnancy and postpartum

    Wang, X., Zhan, Y., Rytting, E., Patrikeeva, S. L., Nanovskaya, T. N., Clark, S., Jackson, A., Venkataramanan, R., Caritis, S., Hankins, G. D. V., & Ahmed, M. S. (2010, September). Pharmacokinetics of famotidine during pregnancy and postpartum. American College of clinical Pharmacology 39th Annual Meeting, Baltimore, MD.
  • Pharmacotherapy and pregnancy: Highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy

    Haas, D. M., Hebert, M. F., Soldin, O. P., Flockhart, D. A., Madadi, P., Nocon, J. J., Chambers, C. D., Hankins, G. D., Clark, S., Wisner, K. L., Li, L., Renbarger, J. L., & Leraman, L. A. (2009 Dec). Pharmacotherapy and pregnancy: Highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy. Clinical and Translational Science, 2(6), 439–443. doi: 10.1111/j.1752-8062.2009.00166.x. (PMID: 20443937)
  • Personalized pharmacotherapy for women: Focus on SSRIs

    Haas, D. M. (2009, February 5). PREGMED: Personalized pharmacotherapy for women: Focus on SSRIs. North American Society for Psychosocial Obstetrics/ Marcé Society National Meeting.
  • In vivo and in vitro metabolism of glyburide by human placenta

    Zharikova, O. L., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2008, September). In vivo and in vitro metabolism of glyburide by human placenta. International Federation of Placenta Associations 2008 Meeting, Seggau Castle, Austria.
  • Metabolism of 17a-hydroxyprogesterone caproate by the dually perfused human placental lobule

    Hemauer, S. J., Yan, R., Patrikeeva, S. L., Mattison, D., Hankins, G. D. V., Ahmed, M. S., & Nanovskaya, T. N. (2008, January). Metabolism of 17a-hydroxyprogesterone caproate by the dually perfused human placental lobule. 28th Annual Meeting of the Society of Maternal-Fetal Medicine, Dallas, TX. (PMID: 18674659).
  • Investigation of glyburide and its metabolites in urine and plasma of pregnant patients under treatment for gestational diabetes

    Ravindran, S., Zharikova, O. L., Nanovskaya, T. N., Hill, R., Mattison, D., Hankins, G. D. V., & Ahmed, M. S. (2008, April). Investigation of glyburide and its metabolites in urine and plasma of pregnant patients under treatment for gestational diabetes. American Chemical Society National Meeting, New Orleans, LA.
  • Identification of the major human hepatic and placental enzymes responsible for the metabolism of glyburide

    Zharikova, O. L., Fokina, V. M., Nanovskaya, T. N., Ravindran, S., Hill, R., Mattison, D., Hankins, G. D. V., & Ahmed, M. S. (2008, January). Identification of the major human hepatic and placental enzymes responsible for the metabolism of glyburide. 28th Annual Meeting of the Society for Maternal-Fetal Medicine, Dallas, TX.
  • Effect of chorion-decidua on prostaglandin E2 production in human fetal membranes

    Harirah, H. M., Zaman, W., Ahmed, M. S., & Hankins, G. D. V. (2007, February). Effect of chorion-decidua on prostaglandin E2 production in human fetal membranes. 27th Annual Meeting of the Society for Maternal- Fetal Medicine, San Francisco, CA.
  • Human placental transfer of 17a-hydroxyprogestrone caproate

    Hemauer, S. J., Patrikeeva, S. L., Hankins, G. D. V., Ahmed, M. S., & Nanovskaya, T. N. (2007, February). Human placental transfer of 17a-hydroxyprogestrone caproate. 27th Annual Meeting of the Society for Maternal- Fetal Medicine, San Francisco, CA.
  • Transplacental transfer and distribution of rosiglitazone

    Patrikeeva, S. L., Hemauer, S. J., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2007, February). Transplacental transfer and distribution of rosiglitazone. 27th Annual Meeting of the Society for Maternal- Fetal Medicine, San Francisco, CA.
  • The effect of esterases on 17a-hydroxyprogesterone caproate

    Yan, R., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2007, February). The effect of esterases on 17a-hydroxyprogesterone caproate. 27th Annual Meeting of the Society for Maternal- Fetal Medicine, San Francisco, CA.
  • The role of the placenta in metabolism of glyburide in human and baboon

    Zharikova, O. L., Ravindran, S., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2007, February). The role of the placenta in metabolism of glyburide in human and baboon. 27th Annual Meeting of the Society for Maternal- Fetal Medicine, San Francisco, CA.
  • Effect of the contact between the amnion and chorion-decidua layers in human fetal membranes on prostaglandin production

    Harirah, H. M., Borahay, M., Wahiduz, Z., Ahmed, M. S., & Hankins, G. D. V. (2006 Feb). Effect of the contact between the amnion and chorion-decidua layers in human fetal membranes on prostaglandin production. 26th Annual Meeting of the Society for Maternal-Fetal Medicine, Miami, FL.
  • The Effect of chorion-decidua on prostaglandin E2 production in human fetal membranes

    Harirah, H. M., Zaman, W., Ahmed, M. S., & Hankins, G. D. V. (2006 Feb). Effect of chorion-decidua on prostaglandin E2 production in human fetal membranes. . 26th Annual Meeting of the Society for Maternal-Fetal Medicine, Miami, FL.
  • Metabolism of glibenclamide (glyburide) by human placenta

    Jain, S., Zharikova, O. L., Selvan, R., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2006 Feb). Metabolism of glibenclamide (glyburide) by human placenta. 26th Annual Meeting of the Society for Maternal-Fetal Medicine, Miami, FL.
  • The transfer of glyburide across human placenta obtained from healthy and diabetic patients and the role of human serum albumin

    Nekhayeva, I. A., Nanovskaya, T. N., Dziuba, N., Hankins, G. D. V., & Ahmed, M. S. (2006 Feb). The transfer of glyburide across human placenta obtained from healthy and diabetic patients and the role of human serum albumin. 26th Annual Meeting of the Society for Maternal-Fetal Medicine, Miami, FL.
  • Transplacental transfer and distribution of rosiglitazone. 26th Annual Meeting

    Patrikeeva, S. L., Hemauer, S. J., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2006 Feb). Transplacental transfer and distribution of rosiglitazone. 26th Annual Meeting of the Society for Maternal-Fetal Medicine, Miami, FL.
  • Metabolism of glyburide by microsomes from human liver and placenta: A study by HPLC-MS

    Ravindran, S., Zharikova, O. L., Hill, R. A., Nanovskaya, T. N., Hankins, G. D. V., & Ahmed, M. S. (2006 Feb). Metabolism of glyburide by microsomes from human liver and placenta: A study by HPLC-MS. 26th Annual Meeting of the Society for Maternal-Fetal Medicine, Miami, FL.
  • Improving Outcomes for Depressed Mothers and Children.Presentation:Developmental Outcomes for SSRI-treated and Depressed Pregnant Women

    International Association of Women’s Mental Health.Symposium Chair:Improving Outcomes for Depressed Mothers and Children.Presentation:Developmental Outcomes for SSRI-treated and Depressed Pregnant Women.Tokyo, Japan 2015.
  • SSRI Treatment of Depression—Are We Asking the Right Questions?

    Arizona Psychiatric Society:SSRI Treatment of Depression—Are We Asking the Right Questions?Phoenix, Arizona 2015.
  • American Psychiatric Association Workshop:To Treat or Not To Treat, Is that the Question?

    American Psychiatric Association Workshop:To Treat or Not To Treat, Is that the Question?Toronto, Canada, 2015.
  • American Society of Clinical Psychopharmacology:Optimal Management of Antidepressant Dose Across Pregnancy

    American Society of Clinical Psychopharmacology:Optimal Management of Antidepressant Dose Across Pregnancy (symposium).Miami, FL, 2015.
  • Developmental Impact of SSRI Exposure during Pregnancy

    MotherToBaby/Organization of Teratology Information Specialists:Developmental Impact of SSRI Exposure during Pregnancy.Montreal, Canada, 2015.
  • European College of Neuropsychopharmacology (ECNP), 28th annual Congress.Invited presentation:SSRI treatment during pregnancy:Are We Asking the Right Questions?

    European College of Neuropsychopharmacology (ECNP), 28th annual Congress.Invited presentation:SSRI treatment during pregnancy:Are We Asking the Right Questions?Amsterdam, Netherlands, 2015.
  • Nordic Marcé Society for Perinatal Mental Health, inaugural meeting.Keynote speaker:Antidepressant Use during Pregnancy

    Nordic Marcé Society for Perinatal Mental Health, inaugural meeting.Keynote speaker:Antidepressant Use during Pregnancy.Oslo, Norway, 2015.
  • Antidepressant Treatment and Documentation Advice; Lithium, Benzodiazepines and Hypnotics, for Translational Research in Perinatal Mental Health

    Practical Psychopharmacology during Pregnancy and Breastfeeding –Pre-conference Training:Antidepressant Treatment and Documentation Advice; Lithium, Benzodiazepines and Hypnotics, for Translational Research in Perinatal Mental Health, 2nd Biennial Perinatal Mental Health Conference.Nov 4-6, Feinberg Conference Center, Northwestern University, Chicago, IL, 2015.
  • SSRI and Anxiolytic Use during Pregnancy

    North American Society for Psychosocial Obstetrics and Gynecology, biennial meeting.SSRI and Anxiolytic Use during Pregnancy.New York, New York, 2016.
  • Pharmacologic Treatment of Women with Bipolar Disorder

    International Society for Psychosomatic Obstetrics and Gynecology, annual meeting symposium.Pharmacologic Treatment of Women with Bipolar Disorder.Malaga, Spain, 2016.
  • MotherToBaby/Organization of Teratology Information Specialists:SSRI in Pregnancy:Are We Asking the Right Questions?

    MotherToBaby/Organization of Teratology Information Specialists:SSRI in Pregnancy:Are We Asking the Right Questions?Invited Symposium.San Antonio, TX, 2016.
  • Psychiatry Grand Rounds.Brown University, Providence, Rhode Island.SSRI in pregnancy:Are we asking the right questions?

    Psychiatry Grand Rounds.Brown University, Providence, Rhode Island.SSRI in pregnancy:Are we asking the right questions? 2016.
  • Institute for Women’s Health Research Forum, Pravastatin for Preeclampsia in Pregnancy:Path to Prevention

    Institute for Women’s Health Research Forum, Pravastatin for Preeclampsia in Pregnancy:Path to Prevention.(a protocol in our U54 Center grant)Chicago, IL, 2016.
  • Grand Rounds, Yale Department of Obstetrics and Gynecology:Treatment of Depression in Pregnancy:Are We Asking the Right Questions?

    Grand Rounds, Yale Department of Obstetrics and Gynecology:Treatment of Depression in Pregnancy:Are We Asking the Right Questions? 2016.
  • Treatment of Pregnant and Postpartum Women with Mood Disorders

    Grand Rounds, Institute of Living, Department of Psychiatry, Hartford, CT:Treatment of Pregnant and Postpartum Women with Mood Disorders. 2017.
  • Antidepressant Treatment and Documentation Advice; Lithium, Benzodiazepines and Hypnotics, for Translational Research in Perinatal Mental Health, 3rd Biennial Perinatal Mental Health Conference

    Practical Psychopharmacology during Pregnancy and Breastfeeding –Pre-conference Training:Antidepressant Treatment and Documentation Advice; Lithium, Benzodiazepines and Hypnotics, for Translational Research in Perinatal Mental Health, 3rd Biennial Perinatal Mental Health Conference.Northwestern University, Chicago, IL, 2017.
  • Three Decades of Conceptual Evolution

    Illinois Psychiatric Society Women’s Brunch: Antidepressant Treatment for Pregnant Women: Three Decades of Conceptual Evolution. 2017
  • American Psychiatric Association Annual Meeting.Award for Research- Antidepressant Treatment for Pregnant Women:Three Decades of Conceptual Evolution

    American Psychiatric Association Annual Meeting.Award for Research- Antidepressant Treatment for Pregnant Women:Three Decades of Conceptual Evolution, San Diego, CA, 2017.
  • Mood Symptoms in pregnant women with bipolar disorder:How effective is treatment?

    American Society for Clinical Pyschopharmacology, presentation:Optimizing Medication Management for Pregnant Women with Depression; Workshop paper: Mood Symptoms in pregnant women with bipolar disorder:How effective is treatment?Miami, Florida, 2017.
  • International Conference on Neurology and Brain Disorders:Managing Medication Doses for Pregnant Women with Depression

    International Conference on Neurology and Brain Disorders:Managing Medication Doses for Pregnant Women with Depression.Valencia, Spain.June, 2017.
  • The American Academy of Pediatrics National Conference & Exhibition:Symposium:Postpartum depression:Pharmacotherapy during Breastfeeding

    The American Academy of Pediatrics National Conference & Exhibition:Symposium:Postpartum depression:Pharmacotherapy during Breastfeeding, Chicago, IL. 2017
  • Grand Rounds – New York State Psychiatric Institute/Columbia University – New York.Conceptual Advancements in Psychotropic Treatment during Pregnancy

    Grand Rounds – New York State Psychiatric Institute/Columbia University – New York.Conceptual Advancements in Psychotropic Treatment during Pregnancy. 2018.
  • Pittsburg Perinatal Partnership: Practical Update on SSRI in Pregnancy

    Pittsburg Perinatal Partnership: Practical Update on SSRI in Pregnancy, Pittsburgh, PA, 2018.
  • Vivian Pinn Women’s Health Research Keynote Lecture.SSRI Antidepressants in Pregnancy: Research Synthesis and Clinical Pharmacology Update

    Vivian Pinn Women’s Health Research Keynote Lecture.SSRI Antidepressants in Pregnancy: Research Synthesis and Clinical Pharmacology Update. Women’s Health 2018 Conference, Washington, DC.
  • Update on Depression and Bipolar Disorder in Pregnancy.Keynote lecture, 2020 Mom Conference

    Update on Depression and Bipolar Disorder in Pregnancy.Keynote lecture, 2020 Mom Conference, Los Angeles, CA, 2018.
  • Statins for preeclampsia prevention: are we ready for clinical use?. Society for Maternal fetal medicine

    Statins for preeclampsia prevention: are we ready for clinical use?. Society for Maternal fetal medicine, Dallas, TX; Feb 2018
  • Substance Use disorders in Pregnancy workshop. Society for Maternal fetal medicine

    Substance Use disorders in Pregnancy workshop. Society for Maternal fetal medicine, Dallas, TX; Feb 2018
  • The use of lipid lowering drugs in the prevention of preeclampsia. 15th Annual Meeting of the Diabetes in Pregnancy Study Group of North America

    The use of lipid lowering drugs in the prevention of preeclampsia. 15th Annual Meeting of the Diabetes in Pregnancy Study Group of North America, Washington, DC; Nov 2017
  • Pravastatin for the prevention of preeclampsia

    Costantine, M. Pravastatin for the prevention of preeclampsia. Invited Grand Rounds Speaker. University of Utah, Salt Lake City, UT, 2019
  • Use of pravastatin to prevent preeclampsia—update on clinical trial

    Costantine, M. Use of pravastatin to prevent preeclampsia—update on clinical trial. 16th Annual Meeting of the Diabetes in Pregnancy Study Group of North America, Washington, DC, 2019
  • Pravastatin for the prevention of preeclampsia 2019

    Costantine, M. Pravastatin for the prevention of preeclampsia. Invited Grand Rounds Speaker. Christiana Care Health system, Newark, DE, 2019
  • Pravastatin for the prevention of preeclampsia Rockville MD, 2019

    Costantine, M. Pravastatin for the prevention of preeclampsia. Invited Seminar Speaker. Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville MD, 2019

  • Role of Statins in Preventing Placental Disorders of Pregnancy

    Costantine, M. Role of Statins in Preventing Placental Disorders of Pregnancy. The Society for Reproductive Investigation Annual Meeting, Paris, France, 2019
  • Novel Therapies to Prevent Preeclampsia

    Costantine, M.  Novel Therapies to Prevent Preeclampsia. Invited Grand Rounds Speaker. The University of Maryland Department of Obstetrics and Gynecology, 2019
  • Balancing Psychiatric Disease Management and Psychotropic Drug Treatment

    Wisner, K. Teratology Conference. Balancing Psychiatric Disease Management and Psychotropic Drug Treatment, University of South Florida, 2019

  • Antiepileptic Drugs and Pregnancy: Models for Developmental Studies

    Wisner, K. Teratology Conference. Antiepileptic Drugs and Pregnancy:  Models for Developmental Studies. University of South Florida, 2019

  • First International Convention of Perinatal Psychopathology, April 5 – 6; and Workshop Speaker

    Wisner, K.  Keynote Speaker, First International Convention of Perinatal Psychopathology, April 5 – 6;  and Workshop Speaker, Italian Perinatal Mental Health Society, April 8, 2019, Milan, Italy

  • Practical Psychopharmacology during Pregnancy and Breastfeeding–Pre-conference Training: Antidepressant, Anticonvulsants, Benzodiazepines and Hypnotics, for Fourth Biennial Perinatal Mental Health Conference

    Wisner, K. Practical Psychopharmacology during Pregnancy and Breastfeeding–Pre-conference Training:  Antidepressant, Anticonvulsants, Benzodiazepines and Hypnotics, for Fourth Biennial Perinatal Mental Health Conference, 2019, (Marcé of North America).